Cargando…

Angiotensin receptor-neprilysin inhibitor delays progression from paroxysmal to persistent atrial fibrillation

Progression from paroxysmal to persistent atrial fibrillation (AF) is linked to adverse clinical outcomes. The present study sought to clarify whether angiotensin receptor-neprilysin inhibitor (ARNI) can delay AF progression. A retrospective cohort study was conducted on consecutive patients with pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Youzheng, Zhai, Zhenyu, Wang, Jihong, Xia, Zhen, Xia, Zirong, Zhu, Bo, Dong, Quanbing, Li, Qing, Li, Juxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950488/ https://www.ncbi.nlm.nih.gov/pubmed/36823222 http://dx.doi.org/10.1038/s41598-023-30349-w

Ejemplares similares

Angiotensin receptor-neprilysin inhibitor therapy and recurrence of atrial fibrillation after radiofrequency catheter ablation: A propensity-matched cohort study
por: Dong, Youzheng, et al.
Publicado: (2022)

Lowering serum homocysteine in H-type hypertensive patients with atrial fibrillation after radiofrequency catheter ablation to prevent atrial fibrillation recurrence
por: Dong, Youzheng, et al.
Publicado: (2022)

Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation
por: Zhu, Tianyu, et al.
Publicado: (2022)

Left Atrial Dysfunction, Fibrosis and the Risk of Thromboembolism in Patients With Paroxysmal and Persistent Atrial Fibrillation
por: Kim, Hee-Dong, et al.
Publicado: (2022)

Understanding the transition from paroxysmal to persistent atrial fibrillation
por: Ciacci, Alberto, et al.
Publicado: (2020)

Plasma Galectin-3 is associated with progression from paroxysmal to persistent atrial fibrillation
por: Wang, Qianhui, et al.
Publicado: (2021)

Effect of angiotensin receptor neprilysin inhibitors on left atrial remodeling and prognosis in heart failure
por: Sun, Yuxi, et al.
Publicado: (2021)

Left atrial effective conducting size predicts atrial fibrillation vulnerability in persistent but not paroxysmal atrial fibrillation
por: Williams, Steven E., et al.
Publicado: (2019)

Left atrial remodeling: Regional differences between paroxysmal and persistent atrial fibrillation
por: Kogawa, Rikitake, et al.
Publicado: (2017)

Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry
por: Wang, Ying, et al.
Publicado: (2019)

Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation
por: Hoffmann, Ellen, et al.
Publicado: (2019)

Persistent Atrial Fibrillation Is Associated with Worse Prognosis Than Paroxysmal Atrial Fibrillation in Acute Cerebral Infarction
por: Naess, Halvor, et al.
Publicado: (2012)

Predisposing Factors Associated With Development of Persistent Compared With Paroxysmal Atrial Fibrillation
por: Sandhu, Roopinder K., et al.
Publicado: (2014)

Identification of atrial complex electrograms by short-coupled extrastimuli in paroxysmal and persistent atrial fibrillation
por: Silva, E, et al.
Publicado: (2023)

Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation
por: Al-Seykal, Ibragim, et al.
Publicado: (2022)

Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021)

Comparison of Prolonged Atrial Electromechanical Delays with Different Definitions in the Discrimination of Patients with Non-Valvular Paroxysmal Atrial Fibrillation
por: Lee, Dong Hyun, et al.
Publicado: (2015)

Cryoballoon ablation of the left atrial posterior wall reduces recurrence of persistent atrial fibrillation in patients with non‐paroxysmal atrial fibrillation
por: Shigeta, Takatoshi, et al.
Publicado: (2021)

Ferroptosis Is a Potential Novel Diagnostic and Therapeutic Target for Patients With Cardiomyopathy
por: Zhai, Zhenyu, et al.
Publicado: (2021)

Autonomic Tone Variations Prior to Onset of Paroxysmal Atrial Fibrillation
por: Zhong, Xia, et al.
Publicado: (2022)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Predictive value of noninducibility after catheter ablation for paroxysmal and persistent atrial fibrillation
por: Tachibana, Shinichi, et al.
Publicado: (2020)

Usefulness of tissue Doppler-derived atrial electromechanical delay for identifying patients with paroxysmal atrial fibrillation
por: Akamatsu, Kanako, et al.
Publicado: (2020)

Inflammatory markers in paroxysmal atrial fibrillation and the protective role of renin-angiotensin-aldosterone system inhibitors
por: ROŞIANU, ŞTEFAN HORIA, et al.
Publicado: (2013)

Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion
por: Demirel, Ozan, et al.
Publicado: (2023)

Left atrial dimensions and left atrial appendage morphology: differences in paroxysmal versus persistent atrial fibrillation patients
por: Pongratz, J, et al.
Publicado: (2023)

Suppression of Paroxysmal Atrial Fibrillation by Pacing
por: Gupta, Anoop K
Publicado: (2003)

Paroxysmal atrial fibrillation in cryptogenic stroke
por: Dangayach, Neha S, et al.
Publicado: (2011)

Hypoadiponectinemia in Patients With Paroxysmal Atrial Fibrillation
por: Choi, Byung Joo, et al.
Publicado: (2012)

Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
por: Ryazanov, A.S., et al.
Publicado: (2023)

Structural and electrophysiological determinants of atrial cardiomyopathy identify remodeling discrepancies between paroxysmal and persistent atrial fibrillation
por: Huang, Taiyuan, et al.
Publicado: (2023)

Difference in risk factors of silent brain infarction between paroxysmal and persistent atrial fibrillation
por: Kim, Andrew T, et al.
Publicado: (2021)

Transcriptome analysis reveals key pathways that vary in patients with paroxysmal and persistent atrial fibrillation
por: Sun, Haoliang, et al.
Publicado: (2021)

Association Between TCF21 Gene Polymorphism with the Incidence of Paroxysmal Atrial Fibrillation and the Efficacy of Radiofrequency Ablation for Patients with Paroxysmal Atrial Fibrillation
por: Zhang, Xianlin, et al.
Publicado: (2022)

Anatomical and electrophysiological factors involved in atrial cardiomyopathy identify remodeling discrepancies between paroxysmal and persistent atrial fibrillation
por: Huang, T, et al.
Publicado: (2023)

Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure
por: Dizaye, Kawa, et al.
Publicado: (2019)

Evaluation of the association between stroke/transient ischemic attack and atrial electromechanical delay in patients with paroxysmal atrial fibrillation
por: Bayar, Nermin, et al.
Publicado: (2016)

Leukocyte Telomere Length Predicts Progression From Paroxysmal to Persistent Atrial Fibrillation in the Long Term After Catheter Ablation
por: Wang, Qianhui, et al.
Publicado: (2022)

Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation
por: Schroder, Jakob, et al.
Publicado: (2019)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cd7nq3l4upvuetncnm90tubo8r